Scholarly Index
Gerd Hasenfuß
Universitätsmedizin Göttingen; 53,493 total citations; 910 total publications; best world rank #73
Universitätsmedizin Göttingen
53,493Total citations
910Total publications
107H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cardiac electrophysiology and arrhythmias | Lifetime | 76 | DE 5 | 99.66 |
| Cardiovascular Function and Risk Factors | Lifetime | 156 | DE 5 | 99.68 |
| Cardiomyopathy and Myosin Studies | Lifetime | 73 | DE 5 | 99.37 |
| Heart Failure Treatment and Management | Lifetime | 220 | DE 12 | 99.15 |
| Cardiac pacing and defibrillation studies | Lifetime | 265 | DE 13 | 99.12 |
| Cardiovascular Effects of Exercise | Lifetime | 204 | DE 9 | 98.63 |
| Ion channel regulation and function | Lifetime | 483 | DE 35 | 98.47 |
| Cardiac Fibrosis and Remodeling | Lifetime | 309 | DE 36 | 95.72 |
| Cardiac Ischemia and Reperfusion | Lifetime | 987 | DE 73 | 94.93 |
| Signaling Pathways in Disease | Lifetime | 829 | DE 68 | 93.04 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 525 | DE 46 | 82.36 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 921 | DE 46 | 94.45 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 916 | DE 82 | 94.41 |
| Heart Failure Treatment and Management | 2021-2025 | 970 | DE 50 | 89.34 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 325 | DE 23 | 74.34 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 716 | DE 57 | 45.55 |